Key points are not available for this paper at this time.
Insulin treatment (Kact, 5 X 10(-9) M) of serum-starved 3T3-L1 adipocytes stimulates a soluble serine/threonine kinase that catalyzes phosphorylation of microtubule-associated protein 2 (MAP-2) in vitro. Maximal activation of MAP-2 kinase activity by 80 nM insulin was observed after 10 min of hormonal stimulation, prior to maximal stimulation of S6 kinase activity (20 min). The insulin-stimulatable MAP-2 kinase activity is not adsorbed to phosphocellulose, whereas the principal S6 kinase activity is retained and elutes at approximately 0.5 M NaCl. The insulin-stimulatable MAP-2 kinase is less stable during incubation at 30 degrees C than S6 kinase activity. Inclusion of phosphatase inhibitors decreases the rate at which the stimulated MAP-2 kinase activity is lost from extract supernatants incubated at 30 degrees C. p-Nitrophenyl phosphate is more effective than DL-phosphotyrosine, whereas DL-phosphoserine is without effect at the concentration used (40 mM). The difference in MAP-2 kinase activity in extract supernatants from control and insulin-treated cells is also preserved after rapid chromatography on Sephadex G-25. These results show that a soluble serine/threonine kinase is rapidly activated by insulin, possibly by phosphorylation of either the kinase itself or an interacting modulator.
Building similarity graph...
Analyzing shared references across papers
Loading...
L. Bryan Ray
KIIT University
T W Sturgill
Howard Hughes Medical Institute
Proceedings of the National Academy of Sciences
Building similarity graph...
Analyzing shared references across papers
Loading...
Ray et al. (Sun,) studied this question.
synapsesocial.com/papers/6a0cd0a03fce92745334d108 — DOI: https://doi.org/10.1073/pnas.84.6.1502
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: